US2003077231A1PendingUtilityA1
Cellulose derivatives
Est. expiryJan 30, 2017(expired)· nominal 20-yr term from priority
A61P 31/04A61P 37/04A61P 31/22A61P 35/00A61P 7/04A61P 7/02A61P 17/02A61K 8/046C08B 15/04A61K 8/731A61K 31/715C08B 31/18A61L 26/0076A61K 9/12A61Q 19/00A61L 15/28C08B 37/0024A61K 8/732A61L 26/0023A61K 9/0014
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Stable microdispersed polyanhydroglucuronic acid and salts thereof contain in their polymeric chain from 8 to 30 percent by weight of carboxyl groups, at least 80 percent by weight of these groups being of the uronic type, at most 5 percent by weight of carbonyl groups including intra- and inter-molecular 2,6 and 3,6 hemiacetals, 2,4-hemialdals and C2 and C3 aldehydes. The molecular mass of the polymeric chain is from 1×10 3 to 3×10 5 Daltons. The microdispersed products are prepared by subjecting a polyanhydroglucuronic acid-containing material to partial or complete hydrolysis and neutralisation in an oxidative environment.
Claims
exact text as granted — not AI-modified1 . A method for preparing a product comprising polyanhydroglucuronic acid and/or salts thereof wherein a polyanhydroglucuronic acid-containing material obtained by oxidation with nitrogen oxides is subjected to partial or complete hydrolysis and neutralisation in an aqueous solution of inorganic and/or organic salts and/or bases in the presence of suitable oxidising agents, the hydrolysate undergoing fractional coagulation to form a stable microdispersed product.
2 . A method as claimed in claim 1 wherein the inorganic and/or organic salts and/or bases used for hydrolysis are chlorides, sulphates, carbonates, formates, or acetates of alkali and/or alkaline earth metals, hydroxides of alkali and/or alkaline earth metals, alkylamines, or alkanolamines, in concentrations ranging from 1 to 10 −3 to 5 mol/l.
3 . A method as claimed in claim 1 wherein the oxidative environment during hydrolysis is established by the presence of oxidising agents selected from one or more of hydrogen, sodium or magnesium peroxide, peroxoacids and their salts, hypochlorites and chlorites.
4 . A method as claimed in claim 1 wherein the hydrolysate undergoes fractional coagulation by a suitable water-miscible organic solvent.
5 . A method as claimed in claim 4 wherein the coagulated product is washed, or dehydrated, using a suitable water-miscible organic solvent, and/or converted, in an appropriate manner, for intended subsequent use.
6 . A method as claimed in claim 1 wherein the procedure is carried out at a pH of from 1 to 12.
7 . A method as claimed in claim 1 wherein the procedure is carried out at a temperature of from 0 to 100° C.
8 . A method as claimed in claim 1 wherein the polyanhydroglucuronic acid-containing material is obtained by oxidation of a suitable polysaccharide, such as native or regenerated cellulose or starch.
9 . Stable microdispersed polyanhydroglucuronic acid and salts thereof wherever prepared by a method as claimed in claim 1 .
10 . Stable microdispersed polyanhydroglucuronic acid and salts thereof containing in their polymeric chain from 8 to 30 percent by weight of carboxyl groups, at least 80 percent by weight of these groups being of the uronic type, at most 5 percent by weight of carbonyl groups, and at most 0.5 percent by weight of bound nitrogen.
11 . Polyanhydroglucuronic acid and salts thereof as claimed in claim 10 containing in their polymeric chain at most 0.2 percent by weight of bound nitrogen.
12 . Polyanhydroglucuronic acid and salts thereof as claimed in claim 10 wherein the molecular mass of the polymeric chain is from 1×10 3 to 3×10 5 Daltons.
13 . Polyanhydroglucuronic acid and salts thereof according to claim 12 wherein the molecular mass of the polymeric chain ranges from 5×10 3 to 1.5×10 5 Daltons.
14 . Polyanhydroglucuronic acid and salts thereof as claimed in claim 10 wherein the content of carboxyl groups is in the range of from 12 to 26 percent by weight, at least 95 percent of these groups being of the uronic type.
15 . Polyanhydroglucuronic acid and salts thereof as claimed in claim 10 containing at most 1 percent by weight of carbonyl groups.
16 . Polyanhydroglucuronic acid and salts thereof according to claim 10 wherein the carbonyl groups are intra- and intermolecular 2,6 and 3,6 hemiacetals, 2,4-hemialdals and C2-C3 aldehydes.
17 . Stable microdispersed polyanhydroglucuronic acid and salts thereof according to claim 10 made up of particles sized from 0.1 to 1000 μm.
18 . Stable microdispersed polyanhydroglucuronic acid and salts thereof according to claim 10 made up of fibres of from 5 to 30 μm in diameter and up to 30 mm length.
19 . A pharmaceutical or cosmetic composition incorporating stable microdispersed polyanhydroglucuronic acid and salts thereof as claimed in claim 10 .
20 . A composition as claimed in claim 19 in the form of a haemostatically active aerosol composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.